Ellagic acid inhibits pancreatic fibrosis in male wistar bonn/kobori rats

Noriaki Suzuki, Atsushi Masamune, Kazuhiro Kikuta, Takashi Watanabe, Kennichi Satoh, Tooru Shimosegawa

研究成果: Article査読

51 被引用数 (Scopus)


The key pathological features of chronic pancreatitis are chronic inflammation, acinar atrophy, and pancreatic fibrosis. We have previously shown that ellagic acid, a plant-derived polyphenol found in fruits and nuts, inhibited activation of pancreatic stellate cells, a major profibrogenic cell type in the pancreas, in vitro. Here we examined whether ellagic acid inhibited the development of pancreatic fibrosis in vivo. Ellagic acid was administered orally in the diet to ten-week-old male Wistar Bonn/Kobori rats, an experimental model of spontaneous chronic pancreatitis, for ten weeks. Ellagic acid (100 mg/kg body weight/day) attenuated pancreatic inflammation and fibrosis. The protective effects were confirmed by an increase in pancreatic weight and decreases in myeloperoxidase activity (an index of neutrophil infiltration), collagen content, transforming growth factor-β1 expression, and the number of α-smooth muscle actin-positive cells (activated pancreatic stellate cells) and ED-1-positive cells (macrophages/monocytes). Ellagic acid inhibited the production of reactive oxygen species in pancreatic stellate cells in response to transforming growth factor-β1 or platelet-derived growth factor. Our results suggest that ellagic acid might be a candidate for treatment of chronic pancreatitis.

ジャーナルDigestive Diseases and Sciences
出版ステータスPublished - 2009 4月

ASJC Scopus subject areas

  • 生理学
  • 消化器病学


「Ellagic acid inhibits pancreatic fibrosis in male wistar bonn/kobori rats」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。